Olivier Chabre
Overview
Explore the profile of Olivier Chabre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
2795
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Frey S, Mosbah H, Donatini G, Brunaud L, Chabre O, Vezzosi D
Ann Endocrinol (Paris)
. 2025 Jan;
86(1):101698.
PMID: 39818285
The choice of therapeutic method for the management of primary hyperparathyroidism depends on the severity of the disease and its complications at the time of diagnosis, the specific situation of...
2.
Cuny T, Reynaud R, Raverot G, Coutant R, Chanson P, Kariyawasam D, et al.
Ann Endocrinol (Paris)
. 2024 Jul;
86(1):101631.
PMID: 39002896
No abstract available.
3.
Magnier O, Schiff I, Cristante J, Chabre O, Veloso M, Bosson J, et al.
Pediatr Blood Cancer
. 2024 May;
71(8):e31074.
PMID: 38778452
Background: Adult- and adolescent-onset neuroblastomas are rare, with no established therapy. In addition, rare pheochromocytomas may harbor neuroblastic components. This study was designed to collect epidemiological, diagnostic and therapeutic data...
4.
Humbert L, Proust-Lemoine E, Dubucquoi S, Kemp E, Saugier-Veber P, Fabien N, et al.
J Clin Endocrinol Metab
. 2024 Apr;
110(3):e757-e773.
PMID: 38605470
Background: Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome is a rare disease caused by biallelic mutations of the AIRE gene, usually presenting with the triad hypoparathyroidism-adrenal failure-chronic mucocutaneous candidiasis (CMC) and nonendocrine manifestations....
5.
Gatta-Cherifi B, Mohammedi K, Cariou T, Poitou C, Touraine P, Raverot G, et al.
Eur J Endocrinol
. 2024 Mar;
190(4):257-265.
PMID: 38450721
Importance: A major issue in the management of craniopharyngioma-related obesity (CRO) is the ineffectiveness of the current therapeutic approaches. Objective: To study the efficacy of glucagon-like peptide-1 analogs compared with...
6.
Chabre O, Lazard A, Muller M, Chaffanjon P, Gay E, Cristante J
J Clin Endocrinol Metab
. 2024 Jan;
109(6):e1477-e1478.
PMID: 38227902
No abstract available.
7.
Isand K, Feelders R, Brue T, Toth M, Deutschbein T, Reincke M, et al.
Eur J Endocrinol
. 2023 Dec;
190(1):75-85.
PMID: 38146835
Objective: The aim of this study was to evaluate the prevalence of venous thromboembolism (VTE) in patients included in the European Registry on Cushing's syndrome (ERCUSYN), compare their clinical characteristics...
8.
Ghalawinji A, Drezet L, Chaffanjon P, Muller M, Sturm N, Simiand A, et al.
J Clin Endocrinol Metab
. 2023 Nov;
109(4):1000-1011.
PMID: 37962981
Objective: When transsphenoidal surgery (TSS) does not cure Cushing's disease (CD), 4 treatments are available: drug treatment (DT), second TSS (2nd TSS), bilateral adrenalectomy (BA), and pituitary radiotherapy (PR). DT...
9.
Terzolo M, Fassnacht M, Perotti P, Libe R, Kastelan D, Lacroix A, et al.
Lancet Diabetes Endocrinol
. 2023 Aug;
11(10):720-730.
PMID: 37619579
Background: Adjuvant treatment with mitotane is commonly used after resection of adrenocortical carcinoma; however, treatment remains controversial, particularly if risk of recurrence is not high. We aimed to assess the...
10.
Brue T, Rahabi H, Barry A, Barlier A, Bertherat J, Borson-Chazot F, et al.
Ann Endocrinol (Paris)
. 2023 Aug;
84(6):697-710.
PMID: 37579837
Acromegaly is a rare disease with prevalence of approximately 60 cases per million, slight female predominance and peak onset in adults in the fourth decade. Clinical diagnosis is often delayed...